StockWatch
·
Pharmaceuticals
Board Meeting12 Nov 2026, 01:10 pm

Caplin Point Board Approves Un-audited Financial Results for Q2 FY27

AI Summary

Caplin Point Laboratories Ltd announced that its Board of Directors, in a meeting held on November 12, 2026, approved the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company also released a press release, an investor presentation, and a limited review report along with the financial results. The meeting commenced at 11:15 AM and concluded at 1:00 PM.

Key Highlights

  • Board meeting held on November 12, 2026.
  • Approved un-audited standalone and consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Limited Review Report and investor presentation also released.
  • Meeting duration was 1 hour and 45 minutes.